Research use only · Lyophilised material · Not a medicine · Not for human or veterinary use · Disclaimer

Sable · Question

What is the difference between GHK-Cu and Tirzepatide?

GHK-Cu is a copper(II) complex of the tripeptide GHK, first identified in human plasma, and widely studied in skin-biology, cosmetic-science and wound-model research (peptide-copper complex, MW about 402.92 g/mol).

Research use only. Not for human consumption. No health claims.

Last verified 2026-10-10

What is the difference between GHK-Cu and Tirzepatide?

GHK-Cu is a copper(II) complex of the tripeptide GHK, first identified in human plasma, and widely studied in skin-biology, cosmetic-science and wound-model research (peptide-copper complex, MW about 402.92 g/mol).

Which is heavier, GHK-Cu or Tirzepatide?

GHK-Cu has a molecular weight of about 402.92 g/mol and Tirzepatide about 4813 g/mol (PubChem), so Tirzepatide is heavier by 4,410.1 g/mol, a ratio of 11.95. This means 1 mg of GHK-Cu contains 2,481.9 nmol versus 207.8 nmol for Tirzepatide.

How many mg of Tirzepatide are equimolar to 1 mg of GHK-Cu?

1 mg of GHK-Cu (MW 402.92) is 2,481.9 nmol. The same number of moles of Tirzepatide (MW 4813) weighs 11.945 mg. Equimolar comparisons matter when testing two compounds side by side in the same assay.

Compare the molecular formulas of GHK-Cu and Tirzepatide

PubChem lists GHK-Cu as C14H23CuN6O4+ (402.92 g/mol) and Tirzepatide as C225H348N48O68 (4813 g/mol). GHK-Cu is a peptide-copper complex; Tirzepatide is a peptide (lipidated). These formulas refer to the parent compounds without salt counter-ions.

A 5 mg vial of GHK-Cu equals how many mg of Tirzepatide in moles?

5 mg of GHK-Cu (MW 402.92) is 12.409 µmol. The same amount of Tirzepatide (MW 4813) would weigh 59.726 mg. This equimolar conversion lets two compounds be compared at matched molar amounts in the same experiment.

A 50 mg vial of GHK-Cu equals how many mg of Tirzepatide in moles?

50 mg of GHK-Cu (MW 402.92) is 124.1 µmol. The same amount of Tirzepatide (MW 4813) would weigh 597.3 mg. This equimolar conversion lets two compounds be compared at matched molar amounts in the same experiment.

A 10 mg vial of GHK-Cu equals how many mg of Tirzepatide in moles?

10 mg of GHK-Cu (MW 402.92) is 24.819 µmol. The same amount of Tirzepatide (MW 4813) would weigh 119.5 mg. This equimolar conversion lets two compounds be compared at matched molar amounts in the same experiment.

A 20 mg vial of GHK-Cu equals how many mg of Tirzepatide in moles?

20 mg of GHK-Cu (MW 402.92) is 49.638 µmol. The same amount of Tirzepatide (MW 4813) would weigh 238.9 mg. This equimolar conversion lets two compounds be compared at matched molar amounts in the same experiment.

A 30 mg vial of GHK-Cu equals how many mg of Tirzepatide in moles?

30 mg of GHK-Cu (MW 402.92) is 74.456 µmol. The same amount of Tirzepatide (MW 4813) would weigh 358.4 mg. This equimolar conversion lets two compounds be compared at matched molar amounts in the same experiment.

A 100 mg vial of GHK-Cu equals how many mg of Tirzepatide in moles?

100 mg of GHK-Cu (MW 402.92) is 248.2 µmol. The same amount of Tirzepatide (MW 4813) would weigh 1,194.5 mg. This equimolar conversion lets two compounds be compared at matched molar amounts in the same experiment.

A 20 mg vial of Tirzepatide equals how many mg of GHK-Cu in moles?

20 mg of Tirzepatide (MW 4813) is 4.155 µmol. The same amount of GHK-Cu (MW 402.92) would weigh 1.674 mg. This equimolar conversion lets two compounds be compared at matched molar amounts in the same experiment.

A 10 mg vial of Tirzepatide equals how many mg of GHK-Cu in moles?

10 mg of Tirzepatide (MW 4813) is 2.078 µmol. The same amount of GHK-Cu (MW 402.92) would weigh 0.8371 mg. This equimolar conversion lets two compounds be compared at matched molar amounts in the same experiment.

A 5 mg vial of Tirzepatide equals how many mg of GHK-Cu in moles?

5 mg of Tirzepatide (MW 4813) is 1.039 µmol. The same amount of GHK-Cu (MW 402.92) would weigh 0.4186 mg. This equimolar conversion lets two compounds be compared at matched molar amounts in the same experiment.

A 30 mg vial of Tirzepatide equals how many mg of GHK-Cu in moles?

30 mg of Tirzepatide (MW 4813) is 6.233 µmol. The same amount of GHK-Cu (MW 402.92) would weigh 2.511 mg. This equimolar conversion lets two compounds be compared at matched molar amounts in the same experiment.

A 40 mg vial of Tirzepatide equals how many mg of GHK-Cu in moles?

40 mg of Tirzepatide (MW 4813) is 8.311 µmol. The same amount of GHK-Cu (MW 402.92) would weigh 3.349 mg. This equimolar conversion lets two compounds be compared at matched molar amounts in the same experiment.

A 15 mg vial of Tirzepatide equals how many mg of GHK-Cu in moles?

15 mg of Tirzepatide (MW 4813) is 3.117 µmol. The same amount of GHK-Cu (MW 402.92) would weigh 1.256 mg. This equimolar conversion lets two compounds be compared at matched molar amounts in the same experiment.

A 60 mg vial of Tirzepatide equals how many mg of GHK-Cu in moles?

60 mg of Tirzepatide (MW 4813) is 12.466 µmol. The same amount of GHK-Cu (MW 402.92) would weigh 5.023 mg. This equimolar conversion lets two compounds be compared at matched molar amounts in the same experiment.

More questions about ghk-cu

A CoA for every lot; each vial carries a printed lot number that matches it. Ask with the lot number and we send it.

Cite this

Research use only. Not for consumption. No health claims.

Plain

Sable Peptides. (2026). What is the difference between GHK-Cu and Tirzepatide?. UK Research Peptide Reference. Retrieved 11 October 2026, from https://www.sablepeptides.co.uk/questions/compare/ghk-cu-vs-tirzepatide/#sqa-038942

APA

Sable Peptides. (2026, October 11). *What is the difference between GHK-Cu and Tirzepatide?*. UK Research Peptide Reference. https://www.sablepeptides.co.uk/questions/compare/ghk-cu-vs-tirzepatide/#sqa-038942

BibTeX

@misc{sable_#sqa-038942_2026,
  author = {{Sable Peptides}},
  title = {{What is the difference between GHK-Cu and Tirzepatide?}},
  year = {2026},
  howpublished = {\url{https://www.sablepeptides.co.uk/questions/compare/ghk-cu-vs-tirzepatide/#sqa-038942}},
  note = {Accessed 11 October 2026. CC BY 4.0}
}

Badge

<a href="https://www.sablepeptides.co.uk/ref"><img src="https://www.sablepeptides.co.uk/badge/ref.svg" alt="Data: UK Research Peptide Reference — Sable Peptides" width="220" height="40"></a>

Date modified: 2026-10-10